Global Vascular Protective Agents Market Growth 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
Vascular protectors are designed to protect the integrity of the vascular lining, improve vascular function, prevent or reduce vascular damage, and thus reduce the risk of cardiovascular disease. This type of drug works through a variety of mechanisms, such as anti-oxidation, anti-inflammation, improving endothelial function, inhibiting platelet aggregation, and reducing vascular sclerosis. Vascular protectors are widely used in the prevention and treatment of diseases such as atherosclerosis, myocardial infarction, stroke, and diabetes-related vascular complications.
The global Vascular Protective Agents market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
LP Information, Inc. (LPI) ' newest research report, the “Vascular Protective Agents Industry Forecast” looks at past sales and reviews total world Vascular Protective Agents sales in 2023, providing a comprehensive analysis by region and market sector of projected Vascular Protective Agents sales for 2024 through 2030. With Vascular Protective Agents sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Vascular Protective Agents industry.
This Insight Report provides a comprehensive analysis of the global Vascular Protective Agents landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Vascular Protective Agents portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Vascular Protective Agents market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Vascular Protective Agents and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Vascular Protective Agents.
United States market for Vascular Protective Agents is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Vascular Protective Agents is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Vascular Protective Agents is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Vascular Protective Agents players cover Chengdu Yazhong Biopharmaceutical Co., Ltd., Sichuan Xieli Pharmaceutical Co., Ltd., Nanjing Zhengda Tianqing Pharmaceutical Co., Ltd., Hubei Keyi Pharmaceutical Co., Ltd., Mayinglong Pharmaceutical Group Co., Ltd., etc. In terms of revenue, the global two largest companies occupied for a share nearly
% in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Vascular Protective Agents market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Vascular Protective Agents market?
What factors are driving Vascular Protective Agents market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Vascular Protective Agents market opportunities vary by end market size?
How does Vascular Protective Agents break out by Type, by Application?
Vascular protectors are designed to protect the integrity of the vascular lining, improve vascular function, prevent or reduce vascular damage, and thus reduce the risk of cardiovascular disease. This type of drug works through a variety of mechanisms, such as anti-oxidation, anti-inflammation, improving endothelial function, inhibiting platelet aggregation, and reducing vascular sclerosis. Vascular protectors are widely used in the prevention and treatment of diseases such as atherosclerosis, myocardial infarction, stroke, and diabetes-related vascular complications.
The global Vascular Protective Agents market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
LP Information, Inc. (LPI) ' newest research report, the “Vascular Protective Agents Industry Forecast” looks at past sales and reviews total world Vascular Protective Agents sales in 2023, providing a comprehensive analysis by region and market sector of projected Vascular Protective Agents sales for 2024 through 2030. With Vascular Protective Agents sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Vascular Protective Agents industry.
This Insight Report provides a comprehensive analysis of the global Vascular Protective Agents landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Vascular Protective Agents portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Vascular Protective Agents market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Vascular Protective Agents and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Vascular Protective Agents.
United States market for Vascular Protective Agents is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Vascular Protective Agents is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Vascular Protective Agents is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Vascular Protective Agents players cover Chengdu Yazhong Biopharmaceutical Co., Ltd., Sichuan Xieli Pharmaceutical Co., Ltd., Nanjing Zhengda Tianqing Pharmaceutical Co., Ltd., Hubei Keyi Pharmaceutical Co., Ltd., Mayinglong Pharmaceutical Group Co., Ltd., etc. In terms of revenue, the global two largest companies occupied for a share nearly
% in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Vascular Protective Agents market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Diosmin (Citrus Flavonoids)
- Complex Carrageenan Esters
- Heparin
- Polysaccharide Polysulfate
- Aescin
- Trexerutin
- Hospital
- Clinic
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Chengdu Yazhong Biopharmaceutical Co., Ltd.
- Sichuan Xieli Pharmaceutical Co., Ltd.
- Nanjing Zhengda Tianqing Pharmaceutical Co., Ltd.
- Hubei Keyi Pharmaceutical Co., Ltd.
- Mayinglong Pharmaceutical Group Co., Ltd.
- Xi'an Janssen Pharmaceutical Co., Ltd.
- Sichuan Feideli Pharmaceutical Co., Ltd.
- Changzhou Qianhong Biochemical Pharmaceutical Co., Ltd.
- Yantai Dongcheng Pharmaceutical Group Co., Ltd.
- Nanjing Jianyou Biochemical Pharmaceutical Co., Ltd.
- Wuhan Aimin Pharmaceutical Co., Ltd.
- Jilin Jinsheng Pharmaceutical Co., Ltd.
- Chongqing Huasen Pharmaceutical Co., Ltd.
- Hunan Yige Pharmaceutical Co., Ltd.
- Tonghua Xindongri Pharmaceutical Co., Ltd.
- Shanxi Huakang Pharmaceutical Co., Ltd.
- Guangxi Hercules Pharmaceutical Co., Ltd.
- Globela Pharma
- STELLA
- Sebela Pharmaceuticals Inc.
- Pfizer
- Bioiberica
- Hepac
- Stanex
- Manus Aktteva Biopharma LLP
- Advacare Pharma
What is the 10-year outlook for the global Vascular Protective Agents market?
What factors are driving Vascular Protective Agents market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Vascular Protective Agents market opportunities vary by end market size?
How does Vascular Protective Agents break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Vascular Protective Agents Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Vascular Protective Agents by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Vascular Protective Agents by Country/Region, 2019, 2023 & 2030
2.2 Vascular Protective Agents Segment by Type
2.2.1 Diosmin (Citrus Flavonoids)
2.2.2 Complex Carrageenan Esters
2.2.3 Heparin
2.2.4 Polysaccharide Polysulfate
2.2.5 Aescin
2.2.6 Trexerutin
2.3 Vascular Protective Agents Sales by Type
2.3.1 Global Vascular Protective Agents Sales Market Share by Type (2019-2024)
2.3.2 Global Vascular Protective Agents Revenue and Market Share by Type (2019-2024)
2.3.3 Global Vascular Protective Agents Sale Price by Type (2019-2024)
2.4 Vascular Protective Agents Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Other
2.5 Vascular Protective Agents Sales by Application
2.5.1 Global Vascular Protective Agents Sale Market Share by Application (2019-2024)
2.5.2 Global Vascular Protective Agents Revenue and Market Share by Application (2019-2024)
2.5.3 Global Vascular Protective Agents Sale Price by Application (2019-2024)
3 GLOBAL BY COMPANY
3.1 Global Vascular Protective Agents Breakdown Data by Company
3.1.1 Global Vascular Protective Agents Annual Sales by Company (2019-2024)
3.1.2 Global Vascular Protective Agents Sales Market Share by Company (2019-2024)
3.2 Global Vascular Protective Agents Annual Revenue by Company (2019-2024)
3.2.1 Global Vascular Protective Agents Revenue by Company (2019-2024)
3.2.2 Global Vascular Protective Agents Revenue Market Share by Company (2019-2024)
3.3 Global Vascular Protective Agents Sale Price by Company
3.4 Key Manufacturers Vascular Protective Agents Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Vascular Protective Agents Product Location Distribution
3.4.2 Players Vascular Protective Agents Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR VASCULAR PROTECTIVE AGENTS BY GEOGRAPHIC REGION
4.1 World Historic Vascular Protective Agents Market Size by Geographic Region (2019-2024)
4.1.1 Global Vascular Protective Agents Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Vascular Protective Agents Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Vascular Protective Agents Market Size by Country/Region (2019-2024)
4.2.1 Global Vascular Protective Agents Annual Sales by Country/Region (2019-2024)
4.2.2 Global Vascular Protective Agents Annual Revenue by Country/Region (2019-2024)
4.3 Americas Vascular Protective Agents Sales Growth
4.4 APAC Vascular Protective Agents Sales Growth
4.5 Europe Vascular Protective Agents Sales Growth
4.6 Middle East & Africa Vascular Protective Agents Sales Growth
5 AMERICAS
5.1 Americas Vascular Protective Agents Sales by Country
5.1.1 Americas Vascular Protective Agents Sales by Country (2019-2024)
5.1.2 Americas Vascular Protective Agents Revenue by Country (2019-2024)
5.2 Americas Vascular Protective Agents Sales by Type (2019-2024)
5.3 Americas Vascular Protective Agents Sales by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Vascular Protective Agents Sales by Region
6.1.1 APAC Vascular Protective Agents Sales by Region (2019-2024)
6.1.2 APAC Vascular Protective Agents Revenue by Region (2019-2024)
6.2 APAC Vascular Protective Agents Sales by Type (2019-2024)
6.3 APAC Vascular Protective Agents Sales by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Vascular Protective Agents by Country
7.1.1 Europe Vascular Protective Agents Sales by Country (2019-2024)
7.1.2 Europe Vascular Protective Agents Revenue by Country (2019-2024)
7.2 Europe Vascular Protective Agents Sales by Type (2019-2024)
7.3 Europe Vascular Protective Agents Sales by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Vascular Protective Agents by Country
8.1.1 Middle East & Africa Vascular Protective Agents Sales by Country (2019-2024)
8.1.2 Middle East & Africa Vascular Protective Agents Revenue by Country (2019-2024)
8.2 Middle East & Africa Vascular Protective Agents Sales by Type (2019-2024)
8.3 Middle East & Africa Vascular Protective Agents Sales by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Vascular Protective Agents
10.3 Manufacturing Process Analysis of Vascular Protective Agents
10.4 Industry Chain Structure of Vascular Protective Agents
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Vascular Protective Agents Distributors
11.3 Vascular Protective Agents Customer
12 WORLD FORECAST REVIEW FOR VASCULAR PROTECTIVE AGENTS BY GEOGRAPHIC REGION
12.1 Global Vascular Protective Agents Market Size Forecast by Region
12.1.1 Global Vascular Protective Agents Forecast by Region (2025-2030)
12.1.2 Global Vascular Protective Agents Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country (2025-2030)
12.3 APAC Forecast by Region (2025-2030)
12.4 Europe Forecast by Country (2025-2030)
12.5 Middle East & Africa Forecast by Country (2025-2030)
12.6 Global Vascular Protective Agents Forecast by Type (2025-2030)
12.7 Global Vascular Protective Agents Forecast by Application (2025-2030)
13 KEY PLAYERS ANALYSIS
13.1 Chengdu Yazhong Biopharmaceutical Co., Ltd.
13.1.1 Chengdu Yazhong Biopharmaceutical Co., Ltd. Company Information
13.1.2 Chengdu Yazhong Biopharmaceutical Co., Ltd. Vascular Protective Agents Product Portfolios and Specifications
13.1.3 Chengdu Yazhong Biopharmaceutical Co., Ltd. Vascular Protective Agents Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Chengdu Yazhong Biopharmaceutical Co., Ltd. Main Business Overview
13.1.5 Chengdu Yazhong Biopharmaceutical Co., Ltd. Latest Developments
13.2 Sichuan Xieli Pharmaceutical Co., Ltd.
13.2.1 Sichuan Xieli Pharmaceutical Co., Ltd. Company Information
13.2.2 Sichuan Xieli Pharmaceutical Co., Ltd. Vascular Protective Agents Product Portfolios and Specifications
13.2.3 Sichuan Xieli Pharmaceutical Co., Ltd. Vascular Protective Agents Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Sichuan Xieli Pharmaceutical Co., Ltd. Main Business Overview
13.2.5 Sichuan Xieli Pharmaceutical Co., Ltd. Latest Developments
13.3 Nanjing Zhengda Tianqing Pharmaceutical Co., Ltd.
13.3.1 Nanjing Zhengda Tianqing Pharmaceutical Co., Ltd. Company Information
13.3.2 Nanjing Zhengda Tianqing Pharmaceutical Co., Ltd. Vascular Protective Agents Product Portfolios and Specifications
13.3.3 Nanjing Zhengda Tianqing Pharmaceutical Co., Ltd. Vascular Protective Agents Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Nanjing Zhengda Tianqing Pharmaceutical Co., Ltd. Main Business Overview
13.3.5 Nanjing Zhengda Tianqing Pharmaceutical Co., Ltd. Latest Developments
13.4 Hubei Keyi Pharmaceutical Co., Ltd.
13.4.1 Hubei Keyi Pharmaceutical Co., Ltd. Company Information
13.4.2 Hubei Keyi Pharmaceutical Co., Ltd. Vascular Protective Agents Product Portfolios and Specifications
13.4.3 Hubei Keyi Pharmaceutical Co., Ltd. Vascular Protective Agents Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Hubei Keyi Pharmaceutical Co., Ltd. Main Business Overview
13.4.5 Hubei Keyi Pharmaceutical Co., Ltd. Latest Developments
13.5 Mayinglong Pharmaceutical Group Co., Ltd.
13.5.1 Mayinglong Pharmaceutical Group Co., Ltd. Company Information
13.5.2 Mayinglong Pharmaceutical Group Co., Ltd. Vascular Protective Agents Product Portfolios and Specifications
13.5.3 Mayinglong Pharmaceutical Group Co., Ltd. Vascular Protective Agents Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Mayinglong Pharmaceutical Group Co., Ltd. Main Business Overview
13.5.5 Mayinglong Pharmaceutical Group Co., Ltd. Latest Developments
13.6 Xi'an Janssen Pharmaceutical Co., Ltd.
13.6.1 Xi'an Janssen Pharmaceutical Co., Ltd. Company Information
13.6.2 Xi'an Janssen Pharmaceutical Co., Ltd. Vascular Protective Agents Product Portfolios and Specifications
13.6.3 Xi'an Janssen Pharmaceutical Co., Ltd. Vascular Protective Agents Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Xi'an Janssen Pharmaceutical Co., Ltd. Main Business Overview
13.6.5 Xi'an Janssen Pharmaceutical Co., Ltd. Latest Developments
13.7 Sichuan Feideli Pharmaceutical Co., Ltd.
13.7.1 Sichuan Feideli Pharmaceutical Co., Ltd. Company Information
13.7.2 Sichuan Feideli Pharmaceutical Co., Ltd. Vascular Protective Agents Product Portfolios and Specifications
13.7.3 Sichuan Feideli Pharmaceutical Co., Ltd. Vascular Protective Agents Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Sichuan Feideli Pharmaceutical Co., Ltd. Main Business Overview
13.7.5 Sichuan Feideli Pharmaceutical Co., Ltd. Latest Developments
13.8 Changzhou Qianhong Biochemical Pharmaceutical Co., Ltd.
13.8.1 Changzhou Qianhong Biochemical Pharmaceutical Co., Ltd. Company Information
13.8.2 Changzhou Qianhong Biochemical Pharmaceutical Co., Ltd. Vascular Protective Agents Product Portfolios and Specifications
13.8.3 Changzhou Qianhong Biochemical Pharmaceutical Co., Ltd. Vascular Protective Agents Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Changzhou Qianhong Biochemical Pharmaceutical Co., Ltd. Main Business Overview
13.8.5 Changzhou Qianhong Biochemical Pharmaceutical Co., Ltd. Latest Developments
13.9 Yantai Dongcheng Pharmaceutical Group Co., Ltd.
13.9.1 Yantai Dongcheng Pharmaceutical Group Co., Ltd. Company Information
13.9.2 Yantai Dongcheng Pharmaceutical Group Co., Ltd. Vascular Protective Agents Product Portfolios and Specifications
13.9.3 Yantai Dongcheng Pharmaceutical Group Co., Ltd. Vascular Protective Agents Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Yantai Dongcheng Pharmaceutical Group Co., Ltd. Main Business Overview
13.9.5 Yantai Dongcheng Pharmaceutical Group Co., Ltd. Latest Developments
13.10 Nanjing Jianyou Biochemical Pharmaceutical Co., Ltd.
13.10.1 Nanjing Jianyou Biochemical Pharmaceutical Co., Ltd. Company Information
13.10.2 Nanjing Jianyou Biochemical Pharmaceutical Co., Ltd. Vascular Protective Agents Product Portfolios and Specifications
13.10.3 Nanjing Jianyou Biochemical Pharmaceutical Co., Ltd. Vascular Protective Agents Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Nanjing Jianyou Biochemical Pharmaceutical Co., Ltd. Main Business Overview
13.10.5 Nanjing Jianyou Biochemical Pharmaceutical Co., Ltd. Latest Developments
13.11 Wuhan Aimin Pharmaceutical Co., Ltd.
13.11.1 Wuhan Aimin Pharmaceutical Co., Ltd. Company Information
13.11.2 Wuhan Aimin Pharmaceutical Co., Ltd. Vascular Protective Agents Product Portfolios and Specifications
13.11.3 Wuhan Aimin Pharmaceutical Co., Ltd. Vascular Protective Agents Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 Wuhan Aimin Pharmaceutical Co., Ltd. Main Business Overview
13.11.5 Wuhan Aimin Pharmaceutical Co., Ltd. Latest Developments
13.12 Jilin Jinsheng Pharmaceutical Co., Ltd.
13.12.1 Jilin Jinsheng Pharmaceutical Co., Ltd. Company Information
13.12.2 Jilin Jinsheng Pharmaceutical Co., Ltd. Vascular Protective Agents Product Portfolios and Specifications
13.12.3 Jilin Jinsheng Pharmaceutical Co., Ltd. Vascular Protective Agents Sales, Revenue, Price and Gross Margin (2019-2024)
13.12.4 Jilin Jinsheng Pharmaceutical Co., Ltd. Main Business Overview
13.12.5 Jilin Jinsheng Pharmaceutical Co., Ltd. Latest Developments
13.13 Chongqing Huasen Pharmaceutical Co., Ltd.
13.13.1 Chongqing Huasen Pharmaceutical Co., Ltd. Company Information
13.13.2 Chongqing Huasen Pharmaceutical Co., Ltd. Vascular Protective Agents Product Portfolios and Specifications
13.13.3 Chongqing Huasen Pharmaceutical Co., Ltd. Vascular Protective Agents Sales, Revenue, Price and Gross Margin (2019-2024)
13.13.4 Chongqing Huasen Pharmaceutical Co., Ltd. Main Business Overview
13.13.5 Chongqing Huasen Pharmaceutical Co., Ltd. Latest Developments
13.14 Hunan Yige Pharmaceutical Co., Ltd.
13.14.1 Hunan Yige Pharmaceutical Co., Ltd. Company Information
13.14.2 Hunan Yige Pharmaceutical Co., Ltd. Vascular Protective Agents Product Portfolios and Specifications
13.14.3 Hunan Yige Pharmaceutical Co., Ltd. Vascular Protective Agents Sales, Revenue, Price and Gross Margin (2019-2024)
13.14.4 Hunan Yige Pharmaceutical Co., Ltd. Main Business Overview
13.14.5 Hunan Yige Pharmaceutical Co., Ltd. Latest Developments
13.15 Tonghua Xindongri Pharmaceutical Co., Ltd.
13.15.1 Tonghua Xindongri Pharmaceutical Co., Ltd. Company Information
13.15.2 Tonghua Xindongri Pharmaceutical Co., Ltd. Vascular Protective Agents Product Portfolios and Specifications
13.15.3 Tonghua Xindongri Pharmaceutical Co., Ltd. Vascular Protective Agents Sales, Revenue, Price and Gross Margin (2019-2024)
13.15.4 Tonghua Xindongri Pharmaceutical Co., Ltd. Main Business Overview
13.15.5 Tonghua Xindongri Pharmaceutical Co., Ltd. Latest Developments
13.16 Shanxi Huakang Pharmaceutical Co., Ltd.
13.16.1 Shanxi Huakang Pharmaceutical Co., Ltd. Company Information
13.16.2 Shanxi Huakang Pharmaceutical Co., Ltd. Vascular Protective Agents Product Portfolios and Specifications
13.16.3 Shanxi Huakang Pharmaceutical Co., Ltd. Vascular Protective Agents Sales, Revenue, Price and Gross Margin (2019-2024)
13.16.4 Shanxi Huakang Pharmaceutical Co., Ltd. Main Business Overview
13.16.5 Shanxi Huakang Pharmaceutical Co., Ltd. Latest Developments
13.17 Guangxi Hercules Pharmaceutical Co., Ltd.
13.17.1 Guangxi Hercules Pharmaceutical Co., Ltd. Company Information
13.17.2 Guangxi Hercules Pharmaceutical Co., Ltd. Vascular Protective Agents Product Portfolios and Specifications
13.17.3 Guangxi Hercules Pharmaceutical Co., Ltd. Vascular Protective Agents Sales, Revenue, Price and Gross Margin (2019-2024)
13.17.4 Guangxi Hercules Pharmaceutical Co., Ltd. Main Business Overview
13.17.5 Guangxi Hercules Pharmaceutical Co., Ltd. Latest Developments
13.18 Globela Pharma
13.18.1 Globela Pharma Company Information
13.18.2 Globela Pharma Vascular Protective Agents Product Portfolios and Specifications
13.18.3 Globela Pharma Vascular Protective Agents Sales, Revenue, Price and Gross Margin (2019-2024)
13.18.4 Globela Pharma Main Business Overview
13.18.5 Globela Pharma Latest Developments
13.19 STELLA
13.19.1 STELLA Company Information
13.19.2 STELLA Vascular Protective Agents Product Portfolios and Specifications
13.19.3 STELLA Vascular Protective Agents Sales, Revenue, Price and Gross Margin (2019-2024)
13.19.4 STELLA Main Business Overview
13.19.5 STELLA Latest Developments
13.20 Sebela Pharmaceuticals Inc.
13.20.1 Sebela Pharmaceuticals Inc. Company Information
13.20.2 Sebela Pharmaceuticals Inc. Vascular Protective Agents Product Portfolios and Specifications
13.20.3 Sebela Pharmaceuticals Inc. Vascular Protective Agents Sales, Revenue, Price and Gross Margin (2019-2024)
13.20.4 Sebela Pharmaceuticals Inc. Main Business Overview
13.20.5 Sebela Pharmaceuticals Inc. Latest Developments
13.21 Pfizer
13.21.1 Pfizer Company Information
13.21.2 Pfizer Vascular Protective Agents Product Portfolios and Specifications
13.21.3 Pfizer Vascular Protective Agents Sales, Revenue, Price and Gross Margin (2019-2024)
13.21.4 Pfizer Main Business Overview
13.21.5 Pfizer Latest Developments
13.22 Bioiberica
13.22.1 Bioiberica Company Information
13.22.2 Bioiberica Vascular Protective Agents Product Portfolios and Specifications
13.22.3 Bioiberica Vascular Protective Agents Sales, Revenue, Price and Gross Margin (2019-2024)
13.22.4 Bioiberica Main Business Overview
13.22.5 Bioiberica Latest Developments
13.23 Hepac
13.23.1 Hepac Company Information
13.23.2 Hepac Vascular Protective Agents Product Portfolios and Specifications
13.23.3 Hepac Vascular Protective Agents Sales, Revenue, Price and Gross Margin (2019-2024)
13.23.4 Hepac Main Business Overview
13.23.5 Hepac Latest Developments
13.24 Stanex
13.24.1 Stanex Company Information
13.24.2 Stanex Vascular Protective Agents Product Portfolios and Specifications
13.24.3 Stanex Vascular Protective Agents Sales, Revenue, Price and Gross Margin (2019-2024)
13.24.4 Stanex Main Business Overview
13.24.5 Stanex Latest Developments
13.25 Manus Aktteva Biopharma LLP
13.25.1 Manus Aktteva Biopharma LLP Company Information
13.25.2 Manus Aktteva Biopharma LLP Vascular Protective Agents Product Portfolios and Specifications
13.25.3 Manus Aktteva Biopharma LLP Vascular Protective Agents Sales, Revenue, Price and Gross Margin (2019-2024)
13.25.4 Manus Aktteva Biopharma LLP Main Business Overview
13.25.5 Manus Aktteva Biopharma LLP Latest Developments
13.26 Advacare Pharma
13.26.1 Advacare Pharma Company Information
13.26.2 Advacare Pharma Vascular Protective Agents Product Portfolios and Specifications
13.26.3 Advacare Pharma Vascular Protective Agents Sales, Revenue, Price and Gross Margin (2019-2024)
13.26.4 Advacare Pharma Main Business Overview
13.26.5 Advacare Pharma Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. Vascular Protective Agents Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Vascular Protective Agents Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Diosmin (CitrusFlavonoids)
Table 4. Major Players of Complex Carrageenan Esters
Table 5. Major Players of Heparin
Table 6. Major Players of Polysaccharide Polysulfate
Table 7. Major Players of Aescin
Table 8. Major Players ofTrexerutin
Table 9. Global Vascular Protective Agents Sales byType (2019-2024) & (K Units)
Table 10. Global Vascular Protective Agents Sales Market Share byType (2019-2024)
Table 11. Global Vascular Protective Agents Revenue byType (2019-2024) & ($ million)
Table 12. Global Vascular Protective Agents Revenue Market Share byType (2019-2024)
Table 13. Global Vascular Protective Agents Sale Price byType (2019-2024) & (US$/Unit)
Table 14. Global Vascular Protective Agents Sale by Application (2019-2024) & (K Units)
Table 15. Global Vascular Protective Agents Sale Market Share by Application (2019-2024)
Table 16. Global Vascular Protective Agents Revenue by Application (2019-2024) & ($ million)
Table 17. Global Vascular Protective Agents Revenue Market Share by Application (2019-2024)
Table 18. Global Vascular Protective Agents Sale Price by Application (2019-2024) & (US$/Unit)
Table 19. Global Vascular Protective Agents Sales by Company (2019-2024) & (K Units)
Table 20. Global Vascular Protective Agents Sales Market Share by Company (2019-2024)
Table 21. Global Vascular Protective Agents Revenue by Company (2019-2024) & ($ millions)
Table 22. Global Vascular Protective Agents Revenue Market Share by Company (2019-2024)
Table 23. Global Vascular Protective Agents Sale Price by Company (2019-2024) & (US$/Unit)
Table 24. Key Manufacturers Vascular Protective Agents Producing Area Distribution and Sales Area
Table 25. Players Vascular Protective Agents Products Offered
Table 26. Vascular Protective Agents Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 27. New Products and Potential Entrants
Table 28. Market M&A Activity & Strategy
Table 29. Global Vascular Protective Agents Sales by Geographic Region (2019-2024) & (K Units)
Table 30. Global Vascular Protective Agents Sales Market Share Geographic Region (2019-2024)
Table 31. Global Vascular Protective Agents Revenue by Geographic Region (2019-2024) & ($ millions)
Table 32. Global Vascular Protective Agents Revenue Market Share by Geographic Region (2019-2024)
Table 33. Global Vascular Protective Agents Sales by Country/Region (2019-2024) & (K Units)
Table 34. Global Vascular Protective Agents Sales Market Share by Country/Region (2019-2024)
Table 35. Global Vascular Protective Agents Revenue by Country/Region (2019-2024) & ($ millions)
Table 36. Global Vascular Protective Agents Revenue Market Share by Country/Region (2019-2024)
Table 37. Americas Vascular Protective Agents Sales by Country (2019-2024) & (K Units)
Table 38. Americas Vascular Protective Agents Sales Market Share by Country (2019-2024)
Table 39. Americas Vascular Protective Agents Revenue by Country (2019-2024) & ($ millions)
Table 40. Americas Vascular Protective Agents Sales byType (2019-2024) & (K Units)
Table 41. Americas Vascular Protective Agents Sales by Application (2019-2024) & (K Units)
Table 42. APAC Vascular Protective Agents Sales by Region (2019-2024) & (K Units)
Table 43. APAC Vascular Protective Agents Sales Market Share by Region (2019-2024)
Table 44. APAC Vascular Protective Agents Revenue by Region (2019-2024) & ($ millions)
Table 45. APAC Vascular Protective Agents Sales byType (2019-2024) & (K Units)
Table 46. APAC Vascular Protective Agents Sales by Application (2019-2024) & (K Units)
Table 47. Europe Vascular Protective Agents Sales by Country (2019-2024) & (K Units)
Table 48. Europe Vascular Protective Agents Revenue by Country (2019-2024) & ($ millions)
Table 49. Europe Vascular Protective Agents Sales byType (2019-2024) & (K Units)
Table 50. Europe Vascular Protective Agents Sales by Application (2019-2024) & (K Units)
Table 51. Middle East & Africa Vascular Protective Agents Sales by Country (2019-2024) & (K Units)
Table 52. Middle East & Africa Vascular Protective Agents Revenue Market Share by Country (2019-2024)
Table 53. Middle East & Africa Vascular Protective Agents Sales byType (2019-2024) & (K Units)
Table 54. Middle East & Africa Vascular Protective Agents Sales by Application (2019-2024) & (K Units)
Table 55. Key Market Drivers & Growth Opportunities of Vascular Protective Agents
Table 56. Key Market Challenges & Risks of Vascular Protective Agents
Table 57. Key IndustryTrends of Vascular Protective Agents
Table 58. Vascular Protective Agents Raw Material
Table 59. Key Suppliers of Raw Materials
Table 60. Vascular Protective Agents Distributors List
Table 61. Vascular Protective Agents Customer List
Table 62. Global Vascular Protective Agents SalesForecast by Region (2025-2030) & (K Units)
Table 63. Global Vascular Protective Agents RevenueForecast by Region (2025-2030) & ($ millions)
Table 64. Americas Vascular Protective Agents SalesForecast by Country (2025-2030) & (K Units)
Table 65. Americas Vascular Protective Agents Annual RevenueForecast by Country (2025-2030) & ($ millions)
Table 66. APAC Vascular Protective Agents SalesForecast by Region (2025-2030) & (K Units)
Table 67. APAC Vascular Protective Agents Annual RevenueForecast by Region (2025-2030) & ($ millions)
Table 68. Europe Vascular Protective Agents SalesForecast by Country (2025-2030) & (K Units)
Table 69. Europe Vascular Protective Agents RevenueForecast by Country (2025-2030) & ($ millions)
Table 70. Middle East & Africa Vascular Protective Agents SalesForecast by Country (2025-2030) & (K Units)
Table 71. Middle East & Africa Vascular Protective Agents RevenueForecast by Country (2025-2030) & ($ millions)
Table 72. Global Vascular Protective Agents SalesForecast byType (2025-2030) & (K Units)
Table 73. Global Vascular Protective Agents RevenueForecast byType (2025-2030) & ($ millions)
Table 74. Global Vascular Protective Agents SalesForecast by Application (2025-2030) & (K Units)
Table 75. Global Vascular Protective Agents RevenueForecast by Application (2025-2030) & ($ millions)
Table 76. Chengdu Yazhong Biopharmaceutical Co., Ltd. Basic Information, Vascular Protective Agents Manufacturing Base, Sales Area and Its Competitors
Table 77. Chengdu Yazhong Biopharmaceutical Co., Ltd. Vascular Protective Agents Product Portfolios and Specifications
Table 78. Chengdu Yazhong Biopharmaceutical Co., Ltd. Vascular Protective Agents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 79. Chengdu Yazhong Biopharmaceutical Co., Ltd. Main Business
Table 80. Chengdu Yazhong Biopharmaceutical Co., Ltd. Latest Developments
Table 81. Sichuan Xieli Pharmaceutical Co., Ltd. Basic Information, Vascular Protective Agents Manufacturing Base, Sales Area and Its Competitors
Table 82. Sichuan Xieli Pharmaceutical Co., Ltd. Vascular Protective Agents Product Portfolios and Specifications
Table 83. Sichuan Xieli Pharmaceutical Co., Ltd. Vascular Protective Agents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 84. Sichuan Xieli Pharmaceutical Co., Ltd. Main Business
Table 85. Sichuan Xieli Pharmaceutical Co., Ltd. Latest Developments
Table 86. Nanjing ZhengdaTianqing Pharmaceutical Co., Ltd. Basic Information, Vascular Protective Agents Manufacturing Base, Sales Area and Its Competitors
Table 87. Nanjing ZhengdaTianqing Pharmaceutical Co., Ltd. Vascular Protective Agents Product Portfolios and Specifications
Table 88. Nanjing ZhengdaTianqing Pharmaceutical Co., Ltd. Vascular Protective Agents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 89. Nanjing ZhengdaTianqing Pharmaceutical Co., Ltd. Main Business
Table 90. Nanjing ZhengdaTianqing Pharmaceutical Co., Ltd. Latest Developments
Table 91. Hubei Keyi Pharmaceutical Co., Ltd. Basic Information, Vascular Protective Agents Manufacturing Base, Sales Area and Its Competitors
Table 92. Hubei Keyi Pharmaceutical Co., Ltd. Vascular Protective Agents Product Portfolios and Specifications
Table 93. Hubei Keyi Pharmaceutical Co., Ltd. Vascular Protective Agents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 94. Hubei Keyi Pharmaceutical Co., Ltd. Main Business
Table 95. Hubei Keyi Pharmaceutical Co., Ltd. Latest Developments
Table 96. Mayinglong Pharmaceutical Group Co., Ltd. Basic Information, Vascular Protective Agents Manufacturing Base, Sales Area and Its Competitors
Table 97. Mayinglong Pharmaceutical Group Co., Ltd. Vascular Protective Agents Product Portfolios and Specifications
Table 98. Mayinglong Pharmaceutical Group Co., Ltd. Vascular Protective Agents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 99. Mayinglong Pharmaceutical Group Co., Ltd. Main Business
Table 100. Mayinglong Pharmaceutical Group Co., Ltd. Latest Developments
Table 101. Xi'an Janssen Pharmaceutical Co., Ltd. Basic Information, Vascular Protective Agents Manufacturing Base, Sales Area and Its Competitors
Table 102. Xi'an Janssen Pharmaceutical Co., Ltd. Vascular Protective Agents Product Portfolios and Specifications
Table 103. Xi'an Janssen Pharmaceutical Co., Ltd. Vascular Protective Agents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 104. Xi'an Janssen Pharmaceutical Co., Ltd. Main Business
Table 105. Xi'an Janssen Pharmaceutical Co., Ltd. Latest Developments
Table 106. SichuanFeideli Pharmaceutical Co., Ltd. Basic Information, Vascular Protective Agents Manufacturing Base, Sales Area and Its Competitors
Table 107. SichuanFeideli Pharmaceutical Co., Ltd. Vascular Protective Agents Product Portfolios and Specifications
Table 108. SichuanFeideli Pharmaceutical Co., Ltd. Vascular Protective Agents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 109. SichuanFeideli Pharmaceutical Co., Ltd. Main Business
Table 110. SichuanFeideli Pharmaceutical Co., Ltd. Latest Developments
Table 111. Changzhou Qianhong Biochemical Pharmaceutical Co., Ltd. Basic Information, Vascular Protective Agents Manufacturing Base, Sales Area and Its Competitors
Table 112. Changzhou Qianhong Biochemical Pharmaceutical Co., Ltd. Vascular Protective Agents Product Portfolios and Specifications
Table 113. Changzhou Qianhong Biochemical Pharmaceutical Co., Ltd. Vascular Protective Agents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 114. Changzhou Qianhong Biochemical Pharmaceutical Co., Ltd. Main Business
Table 115. Changzhou Qianhong Biochemical Pharmaceutical Co., Ltd. Latest Developments
Table 116. Yantai Dongcheng Pharmaceutical Group Co., Ltd. Basic Information, Vascular Protective Agents Manufacturing Base, Sales Area and Its Competitors
Table 117. Yantai Dongcheng Pharmaceutical Group Co., Ltd. Vascular Protective Agents Product Portfolios and Specifications
Table 118. Yantai Dongcheng Pharmaceutical Group Co., Ltd. Vascular Protective Agents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 119. Yantai Dongcheng Pharmaceutical Group Co., Ltd. Main Business
Table 120. Yantai Dongcheng Pharmaceutical Group Co., Ltd. Latest Developments
Table 121. Nanjing Jianyou Biochemical Pharmaceutical Co., Ltd. Basic Information, Vascular Protective Agents Manufacturing Base, Sales Area and Its Competitors
Table 122. Nanjing Jianyou Biochemical Pharmaceutical Co., Ltd. Vascular Protective Agents Product Portfolios and Specifications
Table 123. Nanjing Jianyou Biochemical Pharmaceutical Co., Ltd. Vascular Protective Agents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 124. Nanjing Jianyou Biochemical Pharmaceutical Co., Ltd. Main Business
Table 125. Nanjing Jianyou Biochemical Pharmaceutical Co., Ltd. Latest Developments
Table 126. Wuhan Aimin Pharmaceutical Co., Ltd. Basic Information, Vascular Protective Agents Manufacturing Base, Sales Area and Its Competitors
Table 127. Wuhan Aimin Pharmaceutical Co., Ltd. Vascular Protective Agents Product Portfolios and Specifications
Table 128. Wuhan Aimin Pharmaceutical Co., Ltd. Vascular Protective Agents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 129. Wuhan Aimin Pharmaceutical Co., Ltd. Main Business
Table 130. Wuhan Aimin Pharmaceutical Co., Ltd. Latest Developments
Table 131. Jilin Jinsheng Pharmaceutical Co., Ltd. Basic Information, Vascular Protective Agents Manufacturing Base, Sales Area and Its Competitors
Table 132. Jilin Jinsheng Pharmaceutical Co., Ltd. Vascular Protective Agents Product Portfolios and Specifications
Table 133. Jilin Jinsheng Pharmaceutical Co., Ltd. Vascular Protective Agents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 134. Jilin Jinsheng Pharmaceutical Co., Ltd. Main Business
Table 135. Jilin Jinsheng Pharmaceutical Co., Ltd. Latest Developments
Table 136. Chongqing Huasen Pharmaceutical Co., Ltd. Basic Information, Vascular Protective Agents Manufacturing Base, Sales Area and Its Competitors
Table 137. Chongqing Huasen Pharmaceutical Co., Ltd. Vascular Protective Agents Product Portfolios and Specifications
Table 138. Chongqing Huasen Pharmaceutical Co., Ltd. Vascular Protective Agents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 139. Chongqing Huasen Pharmaceutical Co., Ltd. Main Business
Table 140. Chongqing Huasen Pharmaceutical Co., Ltd. Latest Developments
Table 141. Hunan Yige Pharmaceutical Co., Ltd. Basic Information, Vascular Protective Agents Manufacturing Base, Sales Area and Its Competitors
Table 142. Hunan Yige Pharmaceutical Co., Ltd. Vascular Protective Agents Product Portfolios and Specifications
Table 143. Hunan Yige Pharmaceutical Co., Ltd. Vascular Protective Agents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 144. Hunan Yige Pharmaceutical Co., Ltd. Main Business
Table 145. Hunan Yige Pharmaceutical Co., Ltd. Latest Developments
Table 146.Tonghua Xindongri Pharmaceutical Co., Ltd. Basic Information, Vascular Protective Agents Manufacturing Base, Sales Area and Its Competitors
Table 147.Tonghua Xindongri Pharmaceutical Co., Ltd. Vascular Protective Agents Product Portfolios and Specifications
Table 148.Tonghua Xindongri Pharmaceutical Co., Ltd. Vascular Protective Agents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 149.Tonghua Xindongri Pharmaceutical Co., Ltd. Main Business
Table 150.Tonghua Xindongri Pharmaceutical Co., Ltd. Latest Developments
Table 151. Shanxi Huakang Pharmaceutical Co., Ltd. Basic Information, Vascular Protective Agents Manufacturing Base, Sales Area and Its Competitors
Table 152. Shanxi Huakang Pharmaceutical Co., Ltd. Vascular Protective Agents Product Portfolios and Specifications
Table 153. Shanxi Huakang Pharmaceutical Co., Ltd. Vascular Protective Agents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 154. Shanxi Huakang Pharmaceutical Co., Ltd. Main Business
Table 155. Shanxi Huakang Pharmaceutical Co., Ltd. Latest Developments
Table 156. Guangxi Hercules Pharmaceutical Co., Ltd. Basic Information, Vascular Protective Agents Manufacturing Base, Sales Area and Its Competitors
Table 157. Guangxi Hercules Pharmaceutical Co., Ltd. Vascular Protective Agents Product Portfolios and Specifications
Table 158. Guangxi Hercules Pharmaceutical Co., Ltd. Vascular Protective Agents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 159. Guangxi Hercules Pharmaceutical Co., Ltd. Main Business
Table 160. Guangxi Hercules Pharmaceutical Co., Ltd. Latest Developments
Table 161. Globela Pharma Basic Information, Vascular Protective Agents Manufacturing Base, Sales Area and Its Competitors
Table 162. Globela Pharma Vascular Protective Agents Product Portfolios and Specifications
Table 163. Globela Pharma Vascular Protective Agents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 164. Globela Pharma Main Business
Table 165. Globela Pharma Latest Developments
Table 166. STELLA Basic Information, Vascular Protective Agents Manufacturing Base, Sales Area and Its Competitors
Table 167. STELLA Vascular Protective Agents Product Portfolios and Specifications
Table 168. STELLA Vascular Protective Agents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 169. STELLA Main Business
Table 170. STELLA Latest Developments
Table 171. Sebela Pharmaceuticals Inc. Basic Information, Vascular Protective Agents Manufacturing Base, Sales Area and Its Competitors
Table 172. Sebela Pharmaceuticals Inc. Vascular Protective Agents Product Portfolios and Specifications
Table 173. Sebela Pharmaceuticals Inc. Vascular Protective Agents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 174. Sebela Pharmaceuticals Inc. Main Business
Table 175. Sebela Pharmaceuticals Inc. Latest Developments
Table 176. Pfizer Basic Information, Vascular Protective Agents Manufacturing Base, Sales Area and Its Competitors
Table 177. Pfizer Vascular Protective Agents Product Portfolios and Specifications
Table 178. Pfizer Vascular Protective Agents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 179. Pfizer Main Business
Table 180. Pfizer Latest Developments
Table 181. Bioiberica Basic Information, Vascular Protective Agents Manufacturing Base, Sales Area and Its Competitors
Table 182. Bioiberica Vascular Protective Agents Product Portfolios and Specifications
Table 183. Bioiberica Vascular Protective Agents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 184. Bioiberica Main Business
Table 185. Bioiberica Latest Developments
Table 186. Hepac Basic Information, Vascular Protective Agents Manufacturing Base, Sales Area and Its Competitors
Table 187. Hepac Vascular Protective Agents Product Portfolios and Specifications
Table 188. Hepac Vascular Protective Agents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 189. Hepac Main Business
Table 190. Hepac Latest Developments
Table 191. Stanex Basic Information, Vascular Protective Agents Manufacturing Base, Sales Area and Its Competitors
Table 192. Stanex Vascular Protective Agents Product Portfolios and Specifications
Table 193. Stanex Vascular Protective Agents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 194. Stanex Main Business
Table 195. Stanex Latest Developments
Table 196. Manus Aktteva Biopharma LLP Basic Information, Vascular Protective Agents Manufacturing Base, Sales Area and Its Competitors
Table 197. Manus Aktteva Biopharma LLP Vascular Protective Agents Product Portfolios and Specifications
Table 198. Manus Aktteva Biopharma LLP Vascular Protective Agents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 199. Manus Aktteva Biopharma LLP Main Business
Table 200. Manus Aktteva Biopharma LLP Latest Developments
Table 201. Advacare Pharma Basic Information, Vascular Protective Agents Manufacturing Base, Sales Area and Its Competitors
Table 202. Advacare Pharma Vascular Protective Agents Product Portfolios and Specifications
Table 203. Advacare Pharma Vascular Protective Agents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 204. Advacare Pharma Main Business
Table 205. Advacare Pharma Latest Developments
LIST OFFIGURES
Figure 1. Picture of Vascular Protective Agents
Figure 2. Vascular Protective Agents Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Vascular Protective Agents Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Vascular Protective Agents Revenue Growth Rate 2019-2030 ($ millions)
Figure 8. Vascular Protective Agents Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 9. Vascular Protective Agents Sales Market Share by Country/Region (2023)
Figure 10. Vascular Protective Agents Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 11. Product Picture of Diosmin (CitrusFlavonoids)
Figure 12. Product Picture of Complex Carrageenan Esters
Figure 13. Product Picture of Heparin
Figure 14. Product Picture of Polysaccharide Polysulfate
Figure 15. Product Picture of Aescin
Figure 16. Product Picture ofTrexerutin
Figure 17. Global Vascular Protective Agents Sales Market Share byType in 2023
Figure 18. Global Vascular Protective Agents Revenue Market Share byType (2019-2024)
Figure 19. Vascular Protective Agents Consumed in Hospital
Figure 20. Global Vascular Protective Agents Market: Hospital (2019-2024) & (K Units)
Figure 21. Vascular Protective Agents Consumed in Clinic
Figure 22. Global Vascular Protective Agents Market: Clinic (2019-2024) & (K Units)
Figure 23. Vascular Protective Agents Consumed in Other
Figure 24. Global Vascular Protective Agents Market: Other (2019-2024) & (K Units)
Figure 25. Global Vascular Protective Agents Sale Market Share by Application (2023)
Figure 26. Global Vascular Protective Agents Revenue Market Share by Application in 2023
Figure 27. Vascular Protective Agents Sales by Company in 2023 (K Units)
Figure 28. Global Vascular Protective Agents Sales Market Share by Company in 2023
Figure 29. Vascular Protective Agents Revenue by Company in 2023 ($ millions)
Figure 30. Global Vascular Protective Agents Revenue Market Share by Company in 2023
Figure 31. Global Vascular Protective Agents Sales Market Share by Geographic Region (2019-2024)
Figure 32. Global Vascular Protective Agents Revenue Market Share by Geographic Region in 2023
Figure 33. Americas Vascular Protective Agents Sales 2019-2024 (K Units)
Figure 34. Americas Vascular Protective Agents Revenue 2019-2024 ($ millions)
Figure 35. APAC Vascular Protective Agents Sales 2019-2024 (K Units)
Figure 36. APAC Vascular Protective Agents Revenue 2019-2024 ($ millions)
Figure 37. Europe Vascular Protective Agents Sales 2019-2024 (K Units)
Figure 38. Europe Vascular Protective Agents Revenue 2019-2024 ($ millions)
Figure 39. Middle East & Africa Vascular Protective Agents Sales 2019-2024 (K Units)
Figure 40. Middle East & Africa Vascular Protective Agents Revenue 2019-2024 ($ millions)
Figure 41. Americas Vascular Protective Agents Sales Market Share by Country in 2023
Figure 42. Americas Vascular Protective Agents Revenue Market Share by Country (2019-2024)
Figure 43. Americas Vascular Protective Agents Sales Market Share byType (2019-2024)
Figure 44. Americas Vascular Protective Agents Sales Market Share by Application (2019-2024)
Figure 45. United States Vascular Protective Agents Revenue Growth 2019-2024 ($ millions)
Figure 46. Canada Vascular Protective Agents Revenue Growth 2019-2024 ($ millions)
Figure 47. Mexico Vascular Protective Agents Revenue Growth 2019-2024 ($ millions)
Figure 48. Brazil Vascular Protective Agents Revenue Growth 2019-2024 ($ millions)
Figure 49. APAC Vascular Protective Agents Sales Market Share by Region in 2023
Figure 50. APAC Vascular Protective Agents Revenue Market Share by Region (2019-2024)
Figure 51. APAC Vascular Protective Agents Sales Market Share byType (2019-2024)
Figure 52. APAC Vascular Protective Agents Sales Market Share by Application (2019-2024)
Figure 53. China Vascular Protective Agents Revenue Growth 2019-2024 ($ millions)
Figure 54. Japan Vascular Protective Agents Revenue Growth 2019-2024 ($ millions)
Figure 55. South Korea Vascular Protective Agents Revenue Growth 2019-2024 ($ millions)
Figure 56. Southeast Asia Vascular Protective Agents Revenue Growth 2019-2024 ($ millions)
Figure 57. India Vascular Protective Agents Revenue Growth 2019-2024 ($ millions)
Figure 58. Australia Vascular Protective Agents Revenue Growth 2019-2024 ($ millions)
Figure 59. ChinaTaiwan Vascular Protective Agents Revenue Growth 2019-2024 ($ millions)
Figure 60. Europe Vascular Protective Agents Sales Market Share by Country in 2023
Figure 61. Europe Vascular Protective Agents Revenue Market Share by Country (2019-2024)
Figure 62. Europe Vascular Protective Agents Sales Market Share byType (2019-2024)
Figure 63. Europe Vascular Protective Agents Sales Market Share by Application (2019-2024)
Figure 64. Germany Vascular Protective Agents Revenue Growth 2019-2024 ($ millions)
Figure 65.France Vascular Protective Agents Revenue Growth 2019-2024 ($ millions)
Figure 66. UK Vascular Protective Agents Revenue Growth 2019-2024 ($ millions)
Figure 67. Italy Vascular Protective Agents Revenue Growth 2019-2024 ($ millions)
Figure 68. Russia Vascular Protective Agents Revenue Growth 2019-2024 ($ millions)
Figure 69. Middle East & Africa Vascular Protective Agents Sales Market Share by Country (2019-2024)
Figure 70. Middle East & Africa Vascular Protective Agents Sales Market Share byType (2019-2024)
Figure 71. Middle East & Africa Vascular Protective Agents Sales Market Share by Application (2019-2024)
Figure 72. Egypt Vascular Protective Agents Revenue Growth 2019-2024 ($ millions)
Figure 73. South Africa Vascular Protective Agents Revenue Growth 2019-2024 ($ millions)
Figure 74. Israel Vascular Protective Agents Revenue Growth 2019-2024 ($ millions)
Figure 75.Turkey Vascular Protective Agents Revenue Growth 2019-2024 ($ millions)
Figure 76. GCC Countries Vascular Protective Agents Revenue Growth 2019-2024 ($ millions)
Figure 77. Manufacturing Cost Structure Analysis of Vascular Protective Agents in 2023
Figure 78. Manufacturing Process Analysis of Vascular Protective Agents
Figure 79. Industry Chain Structure of Vascular Protective Agents
Figure 80. Channels of Distribution
Figure 81. Global Vascular Protective Agents Sales MarketForecast by Region (2025-2030)
Figure 82. Global Vascular Protective Agents Revenue Market ShareForecast by Region (2025-2030)
Figure 83. Global Vascular Protective Agents Sales Market ShareForecast byType (2025-2030)
Figure 84. Global Vascular Protective Agents Revenue Market ShareForecast byType (2025-2030)
Figure 85. Global Vascular Protective Agents Sales Market ShareForecast by Application (2025-2030)
Figure 86. Global Vascular Protective Agents Revenue Market ShareForecast by Application (2025-2030)
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Vascular Protective Agents Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Vascular Protective Agents by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Vascular Protective Agents by Country/Region, 2019, 2023 & 2030
2.2 Vascular Protective Agents Segment by Type
2.2.1 Diosmin (Citrus Flavonoids)
2.2.2 Complex Carrageenan Esters
2.2.3 Heparin
2.2.4 Polysaccharide Polysulfate
2.2.5 Aescin
2.2.6 Trexerutin
2.3 Vascular Protective Agents Sales by Type
2.3.1 Global Vascular Protective Agents Sales Market Share by Type (2019-2024)
2.3.2 Global Vascular Protective Agents Revenue and Market Share by Type (2019-2024)
2.3.3 Global Vascular Protective Agents Sale Price by Type (2019-2024)
2.4 Vascular Protective Agents Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Other
2.5 Vascular Protective Agents Sales by Application
2.5.1 Global Vascular Protective Agents Sale Market Share by Application (2019-2024)
2.5.2 Global Vascular Protective Agents Revenue and Market Share by Application (2019-2024)
2.5.3 Global Vascular Protective Agents Sale Price by Application (2019-2024)
3 GLOBAL BY COMPANY
3.1 Global Vascular Protective Agents Breakdown Data by Company
3.1.1 Global Vascular Protective Agents Annual Sales by Company (2019-2024)
3.1.2 Global Vascular Protective Agents Sales Market Share by Company (2019-2024)
3.2 Global Vascular Protective Agents Annual Revenue by Company (2019-2024)
3.2.1 Global Vascular Protective Agents Revenue by Company (2019-2024)
3.2.2 Global Vascular Protective Agents Revenue Market Share by Company (2019-2024)
3.3 Global Vascular Protective Agents Sale Price by Company
3.4 Key Manufacturers Vascular Protective Agents Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Vascular Protective Agents Product Location Distribution
3.4.2 Players Vascular Protective Agents Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR VASCULAR PROTECTIVE AGENTS BY GEOGRAPHIC REGION
4.1 World Historic Vascular Protective Agents Market Size by Geographic Region (2019-2024)
4.1.1 Global Vascular Protective Agents Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Vascular Protective Agents Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Vascular Protective Agents Market Size by Country/Region (2019-2024)
4.2.1 Global Vascular Protective Agents Annual Sales by Country/Region (2019-2024)
4.2.2 Global Vascular Protective Agents Annual Revenue by Country/Region (2019-2024)
4.3 Americas Vascular Protective Agents Sales Growth
4.4 APAC Vascular Protective Agents Sales Growth
4.5 Europe Vascular Protective Agents Sales Growth
4.6 Middle East & Africa Vascular Protective Agents Sales Growth
5 AMERICAS
5.1 Americas Vascular Protective Agents Sales by Country
5.1.1 Americas Vascular Protective Agents Sales by Country (2019-2024)
5.1.2 Americas Vascular Protective Agents Revenue by Country (2019-2024)
5.2 Americas Vascular Protective Agents Sales by Type (2019-2024)
5.3 Americas Vascular Protective Agents Sales by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Vascular Protective Agents Sales by Region
6.1.1 APAC Vascular Protective Agents Sales by Region (2019-2024)
6.1.2 APAC Vascular Protective Agents Revenue by Region (2019-2024)
6.2 APAC Vascular Protective Agents Sales by Type (2019-2024)
6.3 APAC Vascular Protective Agents Sales by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Vascular Protective Agents by Country
7.1.1 Europe Vascular Protective Agents Sales by Country (2019-2024)
7.1.2 Europe Vascular Protective Agents Revenue by Country (2019-2024)
7.2 Europe Vascular Protective Agents Sales by Type (2019-2024)
7.3 Europe Vascular Protective Agents Sales by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Vascular Protective Agents by Country
8.1.1 Middle East & Africa Vascular Protective Agents Sales by Country (2019-2024)
8.1.2 Middle East & Africa Vascular Protective Agents Revenue by Country (2019-2024)
8.2 Middle East & Africa Vascular Protective Agents Sales by Type (2019-2024)
8.3 Middle East & Africa Vascular Protective Agents Sales by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Vascular Protective Agents
10.3 Manufacturing Process Analysis of Vascular Protective Agents
10.4 Industry Chain Structure of Vascular Protective Agents
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Vascular Protective Agents Distributors
11.3 Vascular Protective Agents Customer
12 WORLD FORECAST REVIEW FOR VASCULAR PROTECTIVE AGENTS BY GEOGRAPHIC REGION
12.1 Global Vascular Protective Agents Market Size Forecast by Region
12.1.1 Global Vascular Protective Agents Forecast by Region (2025-2030)
12.1.2 Global Vascular Protective Agents Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country (2025-2030)
12.3 APAC Forecast by Region (2025-2030)
12.4 Europe Forecast by Country (2025-2030)
12.5 Middle East & Africa Forecast by Country (2025-2030)
12.6 Global Vascular Protective Agents Forecast by Type (2025-2030)
12.7 Global Vascular Protective Agents Forecast by Application (2025-2030)
13 KEY PLAYERS ANALYSIS
13.1 Chengdu Yazhong Biopharmaceutical Co., Ltd.
13.1.1 Chengdu Yazhong Biopharmaceutical Co., Ltd. Company Information
13.1.2 Chengdu Yazhong Biopharmaceutical Co., Ltd. Vascular Protective Agents Product Portfolios and Specifications
13.1.3 Chengdu Yazhong Biopharmaceutical Co., Ltd. Vascular Protective Agents Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Chengdu Yazhong Biopharmaceutical Co., Ltd. Main Business Overview
13.1.5 Chengdu Yazhong Biopharmaceutical Co., Ltd. Latest Developments
13.2 Sichuan Xieli Pharmaceutical Co., Ltd.
13.2.1 Sichuan Xieli Pharmaceutical Co., Ltd. Company Information
13.2.2 Sichuan Xieli Pharmaceutical Co., Ltd. Vascular Protective Agents Product Portfolios and Specifications
13.2.3 Sichuan Xieli Pharmaceutical Co., Ltd. Vascular Protective Agents Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Sichuan Xieli Pharmaceutical Co., Ltd. Main Business Overview
13.2.5 Sichuan Xieli Pharmaceutical Co., Ltd. Latest Developments
13.3 Nanjing Zhengda Tianqing Pharmaceutical Co., Ltd.
13.3.1 Nanjing Zhengda Tianqing Pharmaceutical Co., Ltd. Company Information
13.3.2 Nanjing Zhengda Tianqing Pharmaceutical Co., Ltd. Vascular Protective Agents Product Portfolios and Specifications
13.3.3 Nanjing Zhengda Tianqing Pharmaceutical Co., Ltd. Vascular Protective Agents Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Nanjing Zhengda Tianqing Pharmaceutical Co., Ltd. Main Business Overview
13.3.5 Nanjing Zhengda Tianqing Pharmaceutical Co., Ltd. Latest Developments
13.4 Hubei Keyi Pharmaceutical Co., Ltd.
13.4.1 Hubei Keyi Pharmaceutical Co., Ltd. Company Information
13.4.2 Hubei Keyi Pharmaceutical Co., Ltd. Vascular Protective Agents Product Portfolios and Specifications
13.4.3 Hubei Keyi Pharmaceutical Co., Ltd. Vascular Protective Agents Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Hubei Keyi Pharmaceutical Co., Ltd. Main Business Overview
13.4.5 Hubei Keyi Pharmaceutical Co., Ltd. Latest Developments
13.5 Mayinglong Pharmaceutical Group Co., Ltd.
13.5.1 Mayinglong Pharmaceutical Group Co., Ltd. Company Information
13.5.2 Mayinglong Pharmaceutical Group Co., Ltd. Vascular Protective Agents Product Portfolios and Specifications
13.5.3 Mayinglong Pharmaceutical Group Co., Ltd. Vascular Protective Agents Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Mayinglong Pharmaceutical Group Co., Ltd. Main Business Overview
13.5.5 Mayinglong Pharmaceutical Group Co., Ltd. Latest Developments
13.6 Xi'an Janssen Pharmaceutical Co., Ltd.
13.6.1 Xi'an Janssen Pharmaceutical Co., Ltd. Company Information
13.6.2 Xi'an Janssen Pharmaceutical Co., Ltd. Vascular Protective Agents Product Portfolios and Specifications
13.6.3 Xi'an Janssen Pharmaceutical Co., Ltd. Vascular Protective Agents Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Xi'an Janssen Pharmaceutical Co., Ltd. Main Business Overview
13.6.5 Xi'an Janssen Pharmaceutical Co., Ltd. Latest Developments
13.7 Sichuan Feideli Pharmaceutical Co., Ltd.
13.7.1 Sichuan Feideli Pharmaceutical Co., Ltd. Company Information
13.7.2 Sichuan Feideli Pharmaceutical Co., Ltd. Vascular Protective Agents Product Portfolios and Specifications
13.7.3 Sichuan Feideli Pharmaceutical Co., Ltd. Vascular Protective Agents Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Sichuan Feideli Pharmaceutical Co., Ltd. Main Business Overview
13.7.5 Sichuan Feideli Pharmaceutical Co., Ltd. Latest Developments
13.8 Changzhou Qianhong Biochemical Pharmaceutical Co., Ltd.
13.8.1 Changzhou Qianhong Biochemical Pharmaceutical Co., Ltd. Company Information
13.8.2 Changzhou Qianhong Biochemical Pharmaceutical Co., Ltd. Vascular Protective Agents Product Portfolios and Specifications
13.8.3 Changzhou Qianhong Biochemical Pharmaceutical Co., Ltd. Vascular Protective Agents Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Changzhou Qianhong Biochemical Pharmaceutical Co., Ltd. Main Business Overview
13.8.5 Changzhou Qianhong Biochemical Pharmaceutical Co., Ltd. Latest Developments
13.9 Yantai Dongcheng Pharmaceutical Group Co., Ltd.
13.9.1 Yantai Dongcheng Pharmaceutical Group Co., Ltd. Company Information
13.9.2 Yantai Dongcheng Pharmaceutical Group Co., Ltd. Vascular Protective Agents Product Portfolios and Specifications
13.9.3 Yantai Dongcheng Pharmaceutical Group Co., Ltd. Vascular Protective Agents Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Yantai Dongcheng Pharmaceutical Group Co., Ltd. Main Business Overview
13.9.5 Yantai Dongcheng Pharmaceutical Group Co., Ltd. Latest Developments
13.10 Nanjing Jianyou Biochemical Pharmaceutical Co., Ltd.
13.10.1 Nanjing Jianyou Biochemical Pharmaceutical Co., Ltd. Company Information
13.10.2 Nanjing Jianyou Biochemical Pharmaceutical Co., Ltd. Vascular Protective Agents Product Portfolios and Specifications
13.10.3 Nanjing Jianyou Biochemical Pharmaceutical Co., Ltd. Vascular Protective Agents Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Nanjing Jianyou Biochemical Pharmaceutical Co., Ltd. Main Business Overview
13.10.5 Nanjing Jianyou Biochemical Pharmaceutical Co., Ltd. Latest Developments
13.11 Wuhan Aimin Pharmaceutical Co., Ltd.
13.11.1 Wuhan Aimin Pharmaceutical Co., Ltd. Company Information
13.11.2 Wuhan Aimin Pharmaceutical Co., Ltd. Vascular Protective Agents Product Portfolios and Specifications
13.11.3 Wuhan Aimin Pharmaceutical Co., Ltd. Vascular Protective Agents Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 Wuhan Aimin Pharmaceutical Co., Ltd. Main Business Overview
13.11.5 Wuhan Aimin Pharmaceutical Co., Ltd. Latest Developments
13.12 Jilin Jinsheng Pharmaceutical Co., Ltd.
13.12.1 Jilin Jinsheng Pharmaceutical Co., Ltd. Company Information
13.12.2 Jilin Jinsheng Pharmaceutical Co., Ltd. Vascular Protective Agents Product Portfolios and Specifications
13.12.3 Jilin Jinsheng Pharmaceutical Co., Ltd. Vascular Protective Agents Sales, Revenue, Price and Gross Margin (2019-2024)
13.12.4 Jilin Jinsheng Pharmaceutical Co., Ltd. Main Business Overview
13.12.5 Jilin Jinsheng Pharmaceutical Co., Ltd. Latest Developments
13.13 Chongqing Huasen Pharmaceutical Co., Ltd.
13.13.1 Chongqing Huasen Pharmaceutical Co., Ltd. Company Information
13.13.2 Chongqing Huasen Pharmaceutical Co., Ltd. Vascular Protective Agents Product Portfolios and Specifications
13.13.3 Chongqing Huasen Pharmaceutical Co., Ltd. Vascular Protective Agents Sales, Revenue, Price and Gross Margin (2019-2024)
13.13.4 Chongqing Huasen Pharmaceutical Co., Ltd. Main Business Overview
13.13.5 Chongqing Huasen Pharmaceutical Co., Ltd. Latest Developments
13.14 Hunan Yige Pharmaceutical Co., Ltd.
13.14.1 Hunan Yige Pharmaceutical Co., Ltd. Company Information
13.14.2 Hunan Yige Pharmaceutical Co., Ltd. Vascular Protective Agents Product Portfolios and Specifications
13.14.3 Hunan Yige Pharmaceutical Co., Ltd. Vascular Protective Agents Sales, Revenue, Price and Gross Margin (2019-2024)
13.14.4 Hunan Yige Pharmaceutical Co., Ltd. Main Business Overview
13.14.5 Hunan Yige Pharmaceutical Co., Ltd. Latest Developments
13.15 Tonghua Xindongri Pharmaceutical Co., Ltd.
13.15.1 Tonghua Xindongri Pharmaceutical Co., Ltd. Company Information
13.15.2 Tonghua Xindongri Pharmaceutical Co., Ltd. Vascular Protective Agents Product Portfolios and Specifications
13.15.3 Tonghua Xindongri Pharmaceutical Co., Ltd. Vascular Protective Agents Sales, Revenue, Price and Gross Margin (2019-2024)
13.15.4 Tonghua Xindongri Pharmaceutical Co., Ltd. Main Business Overview
13.15.5 Tonghua Xindongri Pharmaceutical Co., Ltd. Latest Developments
13.16 Shanxi Huakang Pharmaceutical Co., Ltd.
13.16.1 Shanxi Huakang Pharmaceutical Co., Ltd. Company Information
13.16.2 Shanxi Huakang Pharmaceutical Co., Ltd. Vascular Protective Agents Product Portfolios and Specifications
13.16.3 Shanxi Huakang Pharmaceutical Co., Ltd. Vascular Protective Agents Sales, Revenue, Price and Gross Margin (2019-2024)
13.16.4 Shanxi Huakang Pharmaceutical Co., Ltd. Main Business Overview
13.16.5 Shanxi Huakang Pharmaceutical Co., Ltd. Latest Developments
13.17 Guangxi Hercules Pharmaceutical Co., Ltd.
13.17.1 Guangxi Hercules Pharmaceutical Co., Ltd. Company Information
13.17.2 Guangxi Hercules Pharmaceutical Co., Ltd. Vascular Protective Agents Product Portfolios and Specifications
13.17.3 Guangxi Hercules Pharmaceutical Co., Ltd. Vascular Protective Agents Sales, Revenue, Price and Gross Margin (2019-2024)
13.17.4 Guangxi Hercules Pharmaceutical Co., Ltd. Main Business Overview
13.17.5 Guangxi Hercules Pharmaceutical Co., Ltd. Latest Developments
13.18 Globela Pharma
13.18.1 Globela Pharma Company Information
13.18.2 Globela Pharma Vascular Protective Agents Product Portfolios and Specifications
13.18.3 Globela Pharma Vascular Protective Agents Sales, Revenue, Price and Gross Margin (2019-2024)
13.18.4 Globela Pharma Main Business Overview
13.18.5 Globela Pharma Latest Developments
13.19 STELLA
13.19.1 STELLA Company Information
13.19.2 STELLA Vascular Protective Agents Product Portfolios and Specifications
13.19.3 STELLA Vascular Protective Agents Sales, Revenue, Price and Gross Margin (2019-2024)
13.19.4 STELLA Main Business Overview
13.19.5 STELLA Latest Developments
13.20 Sebela Pharmaceuticals Inc.
13.20.1 Sebela Pharmaceuticals Inc. Company Information
13.20.2 Sebela Pharmaceuticals Inc. Vascular Protective Agents Product Portfolios and Specifications
13.20.3 Sebela Pharmaceuticals Inc. Vascular Protective Agents Sales, Revenue, Price and Gross Margin (2019-2024)
13.20.4 Sebela Pharmaceuticals Inc. Main Business Overview
13.20.5 Sebela Pharmaceuticals Inc. Latest Developments
13.21 Pfizer
13.21.1 Pfizer Company Information
13.21.2 Pfizer Vascular Protective Agents Product Portfolios and Specifications
13.21.3 Pfizer Vascular Protective Agents Sales, Revenue, Price and Gross Margin (2019-2024)
13.21.4 Pfizer Main Business Overview
13.21.5 Pfizer Latest Developments
13.22 Bioiberica
13.22.1 Bioiberica Company Information
13.22.2 Bioiberica Vascular Protective Agents Product Portfolios and Specifications
13.22.3 Bioiberica Vascular Protective Agents Sales, Revenue, Price and Gross Margin (2019-2024)
13.22.4 Bioiberica Main Business Overview
13.22.5 Bioiberica Latest Developments
13.23 Hepac
13.23.1 Hepac Company Information
13.23.2 Hepac Vascular Protective Agents Product Portfolios and Specifications
13.23.3 Hepac Vascular Protective Agents Sales, Revenue, Price and Gross Margin (2019-2024)
13.23.4 Hepac Main Business Overview
13.23.5 Hepac Latest Developments
13.24 Stanex
13.24.1 Stanex Company Information
13.24.2 Stanex Vascular Protective Agents Product Portfolios and Specifications
13.24.3 Stanex Vascular Protective Agents Sales, Revenue, Price and Gross Margin (2019-2024)
13.24.4 Stanex Main Business Overview
13.24.5 Stanex Latest Developments
13.25 Manus Aktteva Biopharma LLP
13.25.1 Manus Aktteva Biopharma LLP Company Information
13.25.2 Manus Aktteva Biopharma LLP Vascular Protective Agents Product Portfolios and Specifications
13.25.3 Manus Aktteva Biopharma LLP Vascular Protective Agents Sales, Revenue, Price and Gross Margin (2019-2024)
13.25.4 Manus Aktteva Biopharma LLP Main Business Overview
13.25.5 Manus Aktteva Biopharma LLP Latest Developments
13.26 Advacare Pharma
13.26.1 Advacare Pharma Company Information
13.26.2 Advacare Pharma Vascular Protective Agents Product Portfolios and Specifications
13.26.3 Advacare Pharma Vascular Protective Agents Sales, Revenue, Price and Gross Margin (2019-2024)
13.26.4 Advacare Pharma Main Business Overview
13.26.5 Advacare Pharma Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. Vascular Protective Agents Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Vascular Protective Agents Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Diosmin (CitrusFlavonoids)
Table 4. Major Players of Complex Carrageenan Esters
Table 5. Major Players of Heparin
Table 6. Major Players of Polysaccharide Polysulfate
Table 7. Major Players of Aescin
Table 8. Major Players ofTrexerutin
Table 9. Global Vascular Protective Agents Sales byType (2019-2024) & (K Units)
Table 10. Global Vascular Protective Agents Sales Market Share byType (2019-2024)
Table 11. Global Vascular Protective Agents Revenue byType (2019-2024) & ($ million)
Table 12. Global Vascular Protective Agents Revenue Market Share byType (2019-2024)
Table 13. Global Vascular Protective Agents Sale Price byType (2019-2024) & (US$/Unit)
Table 14. Global Vascular Protective Agents Sale by Application (2019-2024) & (K Units)
Table 15. Global Vascular Protective Agents Sale Market Share by Application (2019-2024)
Table 16. Global Vascular Protective Agents Revenue by Application (2019-2024) & ($ million)
Table 17. Global Vascular Protective Agents Revenue Market Share by Application (2019-2024)
Table 18. Global Vascular Protective Agents Sale Price by Application (2019-2024) & (US$/Unit)
Table 19. Global Vascular Protective Agents Sales by Company (2019-2024) & (K Units)
Table 20. Global Vascular Protective Agents Sales Market Share by Company (2019-2024)
Table 21. Global Vascular Protective Agents Revenue by Company (2019-2024) & ($ millions)
Table 22. Global Vascular Protective Agents Revenue Market Share by Company (2019-2024)
Table 23. Global Vascular Protective Agents Sale Price by Company (2019-2024) & (US$/Unit)
Table 24. Key Manufacturers Vascular Protective Agents Producing Area Distribution and Sales Area
Table 25. Players Vascular Protective Agents Products Offered
Table 26. Vascular Protective Agents Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 27. New Products and Potential Entrants
Table 28. Market M&A Activity & Strategy
Table 29. Global Vascular Protective Agents Sales by Geographic Region (2019-2024) & (K Units)
Table 30. Global Vascular Protective Agents Sales Market Share Geographic Region (2019-2024)
Table 31. Global Vascular Protective Agents Revenue by Geographic Region (2019-2024) & ($ millions)
Table 32. Global Vascular Protective Agents Revenue Market Share by Geographic Region (2019-2024)
Table 33. Global Vascular Protective Agents Sales by Country/Region (2019-2024) & (K Units)
Table 34. Global Vascular Protective Agents Sales Market Share by Country/Region (2019-2024)
Table 35. Global Vascular Protective Agents Revenue by Country/Region (2019-2024) & ($ millions)
Table 36. Global Vascular Protective Agents Revenue Market Share by Country/Region (2019-2024)
Table 37. Americas Vascular Protective Agents Sales by Country (2019-2024) & (K Units)
Table 38. Americas Vascular Protective Agents Sales Market Share by Country (2019-2024)
Table 39. Americas Vascular Protective Agents Revenue by Country (2019-2024) & ($ millions)
Table 40. Americas Vascular Protective Agents Sales byType (2019-2024) & (K Units)
Table 41. Americas Vascular Protective Agents Sales by Application (2019-2024) & (K Units)
Table 42. APAC Vascular Protective Agents Sales by Region (2019-2024) & (K Units)
Table 43. APAC Vascular Protective Agents Sales Market Share by Region (2019-2024)
Table 44. APAC Vascular Protective Agents Revenue by Region (2019-2024) & ($ millions)
Table 45. APAC Vascular Protective Agents Sales byType (2019-2024) & (K Units)
Table 46. APAC Vascular Protective Agents Sales by Application (2019-2024) & (K Units)
Table 47. Europe Vascular Protective Agents Sales by Country (2019-2024) & (K Units)
Table 48. Europe Vascular Protective Agents Revenue by Country (2019-2024) & ($ millions)
Table 49. Europe Vascular Protective Agents Sales byType (2019-2024) & (K Units)
Table 50. Europe Vascular Protective Agents Sales by Application (2019-2024) & (K Units)
Table 51. Middle East & Africa Vascular Protective Agents Sales by Country (2019-2024) & (K Units)
Table 52. Middle East & Africa Vascular Protective Agents Revenue Market Share by Country (2019-2024)
Table 53. Middle East & Africa Vascular Protective Agents Sales byType (2019-2024) & (K Units)
Table 54. Middle East & Africa Vascular Protective Agents Sales by Application (2019-2024) & (K Units)
Table 55. Key Market Drivers & Growth Opportunities of Vascular Protective Agents
Table 56. Key Market Challenges & Risks of Vascular Protective Agents
Table 57. Key IndustryTrends of Vascular Protective Agents
Table 58. Vascular Protective Agents Raw Material
Table 59. Key Suppliers of Raw Materials
Table 60. Vascular Protective Agents Distributors List
Table 61. Vascular Protective Agents Customer List
Table 62. Global Vascular Protective Agents SalesForecast by Region (2025-2030) & (K Units)
Table 63. Global Vascular Protective Agents RevenueForecast by Region (2025-2030) & ($ millions)
Table 64. Americas Vascular Protective Agents SalesForecast by Country (2025-2030) & (K Units)
Table 65. Americas Vascular Protective Agents Annual RevenueForecast by Country (2025-2030) & ($ millions)
Table 66. APAC Vascular Protective Agents SalesForecast by Region (2025-2030) & (K Units)
Table 67. APAC Vascular Protective Agents Annual RevenueForecast by Region (2025-2030) & ($ millions)
Table 68. Europe Vascular Protective Agents SalesForecast by Country (2025-2030) & (K Units)
Table 69. Europe Vascular Protective Agents RevenueForecast by Country (2025-2030) & ($ millions)
Table 70. Middle East & Africa Vascular Protective Agents SalesForecast by Country (2025-2030) & (K Units)
Table 71. Middle East & Africa Vascular Protective Agents RevenueForecast by Country (2025-2030) & ($ millions)
Table 72. Global Vascular Protective Agents SalesForecast byType (2025-2030) & (K Units)
Table 73. Global Vascular Protective Agents RevenueForecast byType (2025-2030) & ($ millions)
Table 74. Global Vascular Protective Agents SalesForecast by Application (2025-2030) & (K Units)
Table 75. Global Vascular Protective Agents RevenueForecast by Application (2025-2030) & ($ millions)
Table 76. Chengdu Yazhong Biopharmaceutical Co., Ltd. Basic Information, Vascular Protective Agents Manufacturing Base, Sales Area and Its Competitors
Table 77. Chengdu Yazhong Biopharmaceutical Co., Ltd. Vascular Protective Agents Product Portfolios and Specifications
Table 78. Chengdu Yazhong Biopharmaceutical Co., Ltd. Vascular Protective Agents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 79. Chengdu Yazhong Biopharmaceutical Co., Ltd. Main Business
Table 80. Chengdu Yazhong Biopharmaceutical Co., Ltd. Latest Developments
Table 81. Sichuan Xieli Pharmaceutical Co., Ltd. Basic Information, Vascular Protective Agents Manufacturing Base, Sales Area and Its Competitors
Table 82. Sichuan Xieli Pharmaceutical Co., Ltd. Vascular Protective Agents Product Portfolios and Specifications
Table 83. Sichuan Xieli Pharmaceutical Co., Ltd. Vascular Protective Agents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 84. Sichuan Xieli Pharmaceutical Co., Ltd. Main Business
Table 85. Sichuan Xieli Pharmaceutical Co., Ltd. Latest Developments
Table 86. Nanjing ZhengdaTianqing Pharmaceutical Co., Ltd. Basic Information, Vascular Protective Agents Manufacturing Base, Sales Area and Its Competitors
Table 87. Nanjing ZhengdaTianqing Pharmaceutical Co., Ltd. Vascular Protective Agents Product Portfolios and Specifications
Table 88. Nanjing ZhengdaTianqing Pharmaceutical Co., Ltd. Vascular Protective Agents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 89. Nanjing ZhengdaTianqing Pharmaceutical Co., Ltd. Main Business
Table 90. Nanjing ZhengdaTianqing Pharmaceutical Co., Ltd. Latest Developments
Table 91. Hubei Keyi Pharmaceutical Co., Ltd. Basic Information, Vascular Protective Agents Manufacturing Base, Sales Area and Its Competitors
Table 92. Hubei Keyi Pharmaceutical Co., Ltd. Vascular Protective Agents Product Portfolios and Specifications
Table 93. Hubei Keyi Pharmaceutical Co., Ltd. Vascular Protective Agents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 94. Hubei Keyi Pharmaceutical Co., Ltd. Main Business
Table 95. Hubei Keyi Pharmaceutical Co., Ltd. Latest Developments
Table 96. Mayinglong Pharmaceutical Group Co., Ltd. Basic Information, Vascular Protective Agents Manufacturing Base, Sales Area and Its Competitors
Table 97. Mayinglong Pharmaceutical Group Co., Ltd. Vascular Protective Agents Product Portfolios and Specifications
Table 98. Mayinglong Pharmaceutical Group Co., Ltd. Vascular Protective Agents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 99. Mayinglong Pharmaceutical Group Co., Ltd. Main Business
Table 100. Mayinglong Pharmaceutical Group Co., Ltd. Latest Developments
Table 101. Xi'an Janssen Pharmaceutical Co., Ltd. Basic Information, Vascular Protective Agents Manufacturing Base, Sales Area and Its Competitors
Table 102. Xi'an Janssen Pharmaceutical Co., Ltd. Vascular Protective Agents Product Portfolios and Specifications
Table 103. Xi'an Janssen Pharmaceutical Co., Ltd. Vascular Protective Agents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 104. Xi'an Janssen Pharmaceutical Co., Ltd. Main Business
Table 105. Xi'an Janssen Pharmaceutical Co., Ltd. Latest Developments
Table 106. SichuanFeideli Pharmaceutical Co., Ltd. Basic Information, Vascular Protective Agents Manufacturing Base, Sales Area and Its Competitors
Table 107. SichuanFeideli Pharmaceutical Co., Ltd. Vascular Protective Agents Product Portfolios and Specifications
Table 108. SichuanFeideli Pharmaceutical Co., Ltd. Vascular Protective Agents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 109. SichuanFeideli Pharmaceutical Co., Ltd. Main Business
Table 110. SichuanFeideli Pharmaceutical Co., Ltd. Latest Developments
Table 111. Changzhou Qianhong Biochemical Pharmaceutical Co., Ltd. Basic Information, Vascular Protective Agents Manufacturing Base, Sales Area and Its Competitors
Table 112. Changzhou Qianhong Biochemical Pharmaceutical Co., Ltd. Vascular Protective Agents Product Portfolios and Specifications
Table 113. Changzhou Qianhong Biochemical Pharmaceutical Co., Ltd. Vascular Protective Agents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 114. Changzhou Qianhong Biochemical Pharmaceutical Co., Ltd. Main Business
Table 115. Changzhou Qianhong Biochemical Pharmaceutical Co., Ltd. Latest Developments
Table 116. Yantai Dongcheng Pharmaceutical Group Co., Ltd. Basic Information, Vascular Protective Agents Manufacturing Base, Sales Area and Its Competitors
Table 117. Yantai Dongcheng Pharmaceutical Group Co., Ltd. Vascular Protective Agents Product Portfolios and Specifications
Table 118. Yantai Dongcheng Pharmaceutical Group Co., Ltd. Vascular Protective Agents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 119. Yantai Dongcheng Pharmaceutical Group Co., Ltd. Main Business
Table 120. Yantai Dongcheng Pharmaceutical Group Co., Ltd. Latest Developments
Table 121. Nanjing Jianyou Biochemical Pharmaceutical Co., Ltd. Basic Information, Vascular Protective Agents Manufacturing Base, Sales Area and Its Competitors
Table 122. Nanjing Jianyou Biochemical Pharmaceutical Co., Ltd. Vascular Protective Agents Product Portfolios and Specifications
Table 123. Nanjing Jianyou Biochemical Pharmaceutical Co., Ltd. Vascular Protective Agents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 124. Nanjing Jianyou Biochemical Pharmaceutical Co., Ltd. Main Business
Table 125. Nanjing Jianyou Biochemical Pharmaceutical Co., Ltd. Latest Developments
Table 126. Wuhan Aimin Pharmaceutical Co., Ltd. Basic Information, Vascular Protective Agents Manufacturing Base, Sales Area and Its Competitors
Table 127. Wuhan Aimin Pharmaceutical Co., Ltd. Vascular Protective Agents Product Portfolios and Specifications
Table 128. Wuhan Aimin Pharmaceutical Co., Ltd. Vascular Protective Agents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 129. Wuhan Aimin Pharmaceutical Co., Ltd. Main Business
Table 130. Wuhan Aimin Pharmaceutical Co., Ltd. Latest Developments
Table 131. Jilin Jinsheng Pharmaceutical Co., Ltd. Basic Information, Vascular Protective Agents Manufacturing Base, Sales Area and Its Competitors
Table 132. Jilin Jinsheng Pharmaceutical Co., Ltd. Vascular Protective Agents Product Portfolios and Specifications
Table 133. Jilin Jinsheng Pharmaceutical Co., Ltd. Vascular Protective Agents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 134. Jilin Jinsheng Pharmaceutical Co., Ltd. Main Business
Table 135. Jilin Jinsheng Pharmaceutical Co., Ltd. Latest Developments
Table 136. Chongqing Huasen Pharmaceutical Co., Ltd. Basic Information, Vascular Protective Agents Manufacturing Base, Sales Area and Its Competitors
Table 137. Chongqing Huasen Pharmaceutical Co., Ltd. Vascular Protective Agents Product Portfolios and Specifications
Table 138. Chongqing Huasen Pharmaceutical Co., Ltd. Vascular Protective Agents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 139. Chongqing Huasen Pharmaceutical Co., Ltd. Main Business
Table 140. Chongqing Huasen Pharmaceutical Co., Ltd. Latest Developments
Table 141. Hunan Yige Pharmaceutical Co., Ltd. Basic Information, Vascular Protective Agents Manufacturing Base, Sales Area and Its Competitors
Table 142. Hunan Yige Pharmaceutical Co., Ltd. Vascular Protective Agents Product Portfolios and Specifications
Table 143. Hunan Yige Pharmaceutical Co., Ltd. Vascular Protective Agents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 144. Hunan Yige Pharmaceutical Co., Ltd. Main Business
Table 145. Hunan Yige Pharmaceutical Co., Ltd. Latest Developments
Table 146.Tonghua Xindongri Pharmaceutical Co., Ltd. Basic Information, Vascular Protective Agents Manufacturing Base, Sales Area and Its Competitors
Table 147.Tonghua Xindongri Pharmaceutical Co., Ltd. Vascular Protective Agents Product Portfolios and Specifications
Table 148.Tonghua Xindongri Pharmaceutical Co., Ltd. Vascular Protective Agents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 149.Tonghua Xindongri Pharmaceutical Co., Ltd. Main Business
Table 150.Tonghua Xindongri Pharmaceutical Co., Ltd. Latest Developments
Table 151. Shanxi Huakang Pharmaceutical Co., Ltd. Basic Information, Vascular Protective Agents Manufacturing Base, Sales Area and Its Competitors
Table 152. Shanxi Huakang Pharmaceutical Co., Ltd. Vascular Protective Agents Product Portfolios and Specifications
Table 153. Shanxi Huakang Pharmaceutical Co., Ltd. Vascular Protective Agents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 154. Shanxi Huakang Pharmaceutical Co., Ltd. Main Business
Table 155. Shanxi Huakang Pharmaceutical Co., Ltd. Latest Developments
Table 156. Guangxi Hercules Pharmaceutical Co., Ltd. Basic Information, Vascular Protective Agents Manufacturing Base, Sales Area and Its Competitors
Table 157. Guangxi Hercules Pharmaceutical Co., Ltd. Vascular Protective Agents Product Portfolios and Specifications
Table 158. Guangxi Hercules Pharmaceutical Co., Ltd. Vascular Protective Agents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 159. Guangxi Hercules Pharmaceutical Co., Ltd. Main Business
Table 160. Guangxi Hercules Pharmaceutical Co., Ltd. Latest Developments
Table 161. Globela Pharma Basic Information, Vascular Protective Agents Manufacturing Base, Sales Area and Its Competitors
Table 162. Globela Pharma Vascular Protective Agents Product Portfolios and Specifications
Table 163. Globela Pharma Vascular Protective Agents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 164. Globela Pharma Main Business
Table 165. Globela Pharma Latest Developments
Table 166. STELLA Basic Information, Vascular Protective Agents Manufacturing Base, Sales Area and Its Competitors
Table 167. STELLA Vascular Protective Agents Product Portfolios and Specifications
Table 168. STELLA Vascular Protective Agents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 169. STELLA Main Business
Table 170. STELLA Latest Developments
Table 171. Sebela Pharmaceuticals Inc. Basic Information, Vascular Protective Agents Manufacturing Base, Sales Area and Its Competitors
Table 172. Sebela Pharmaceuticals Inc. Vascular Protective Agents Product Portfolios and Specifications
Table 173. Sebela Pharmaceuticals Inc. Vascular Protective Agents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 174. Sebela Pharmaceuticals Inc. Main Business
Table 175. Sebela Pharmaceuticals Inc. Latest Developments
Table 176. Pfizer Basic Information, Vascular Protective Agents Manufacturing Base, Sales Area and Its Competitors
Table 177. Pfizer Vascular Protective Agents Product Portfolios and Specifications
Table 178. Pfizer Vascular Protective Agents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 179. Pfizer Main Business
Table 180. Pfizer Latest Developments
Table 181. Bioiberica Basic Information, Vascular Protective Agents Manufacturing Base, Sales Area and Its Competitors
Table 182. Bioiberica Vascular Protective Agents Product Portfolios and Specifications
Table 183. Bioiberica Vascular Protective Agents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 184. Bioiberica Main Business
Table 185. Bioiberica Latest Developments
Table 186. Hepac Basic Information, Vascular Protective Agents Manufacturing Base, Sales Area and Its Competitors
Table 187. Hepac Vascular Protective Agents Product Portfolios and Specifications
Table 188. Hepac Vascular Protective Agents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 189. Hepac Main Business
Table 190. Hepac Latest Developments
Table 191. Stanex Basic Information, Vascular Protective Agents Manufacturing Base, Sales Area and Its Competitors
Table 192. Stanex Vascular Protective Agents Product Portfolios and Specifications
Table 193. Stanex Vascular Protective Agents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 194. Stanex Main Business
Table 195. Stanex Latest Developments
Table 196. Manus Aktteva Biopharma LLP Basic Information, Vascular Protective Agents Manufacturing Base, Sales Area and Its Competitors
Table 197. Manus Aktteva Biopharma LLP Vascular Protective Agents Product Portfolios and Specifications
Table 198. Manus Aktteva Biopharma LLP Vascular Protective Agents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 199. Manus Aktteva Biopharma LLP Main Business
Table 200. Manus Aktteva Biopharma LLP Latest Developments
Table 201. Advacare Pharma Basic Information, Vascular Protective Agents Manufacturing Base, Sales Area and Its Competitors
Table 202. Advacare Pharma Vascular Protective Agents Product Portfolios and Specifications
Table 203. Advacare Pharma Vascular Protective Agents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 204. Advacare Pharma Main Business
Table 205. Advacare Pharma Latest Developments
LIST OFFIGURES
Figure 1. Picture of Vascular Protective Agents
Figure 2. Vascular Protective Agents Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Vascular Protective Agents Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Vascular Protective Agents Revenue Growth Rate 2019-2030 ($ millions)
Figure 8. Vascular Protective Agents Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 9. Vascular Protective Agents Sales Market Share by Country/Region (2023)
Figure 10. Vascular Protective Agents Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 11. Product Picture of Diosmin (CitrusFlavonoids)
Figure 12. Product Picture of Complex Carrageenan Esters
Figure 13. Product Picture of Heparin
Figure 14. Product Picture of Polysaccharide Polysulfate
Figure 15. Product Picture of Aescin
Figure 16. Product Picture ofTrexerutin
Figure 17. Global Vascular Protective Agents Sales Market Share byType in 2023
Figure 18. Global Vascular Protective Agents Revenue Market Share byType (2019-2024)
Figure 19. Vascular Protective Agents Consumed in Hospital
Figure 20. Global Vascular Protective Agents Market: Hospital (2019-2024) & (K Units)
Figure 21. Vascular Protective Agents Consumed in Clinic
Figure 22. Global Vascular Protective Agents Market: Clinic (2019-2024) & (K Units)
Figure 23. Vascular Protective Agents Consumed in Other
Figure 24. Global Vascular Protective Agents Market: Other (2019-2024) & (K Units)
Figure 25. Global Vascular Protective Agents Sale Market Share by Application (2023)
Figure 26. Global Vascular Protective Agents Revenue Market Share by Application in 2023
Figure 27. Vascular Protective Agents Sales by Company in 2023 (K Units)
Figure 28. Global Vascular Protective Agents Sales Market Share by Company in 2023
Figure 29. Vascular Protective Agents Revenue by Company in 2023 ($ millions)
Figure 30. Global Vascular Protective Agents Revenue Market Share by Company in 2023
Figure 31. Global Vascular Protective Agents Sales Market Share by Geographic Region (2019-2024)
Figure 32. Global Vascular Protective Agents Revenue Market Share by Geographic Region in 2023
Figure 33. Americas Vascular Protective Agents Sales 2019-2024 (K Units)
Figure 34. Americas Vascular Protective Agents Revenue 2019-2024 ($ millions)
Figure 35. APAC Vascular Protective Agents Sales 2019-2024 (K Units)
Figure 36. APAC Vascular Protective Agents Revenue 2019-2024 ($ millions)
Figure 37. Europe Vascular Protective Agents Sales 2019-2024 (K Units)
Figure 38. Europe Vascular Protective Agents Revenue 2019-2024 ($ millions)
Figure 39. Middle East & Africa Vascular Protective Agents Sales 2019-2024 (K Units)
Figure 40. Middle East & Africa Vascular Protective Agents Revenue 2019-2024 ($ millions)
Figure 41. Americas Vascular Protective Agents Sales Market Share by Country in 2023
Figure 42. Americas Vascular Protective Agents Revenue Market Share by Country (2019-2024)
Figure 43. Americas Vascular Protective Agents Sales Market Share byType (2019-2024)
Figure 44. Americas Vascular Protective Agents Sales Market Share by Application (2019-2024)
Figure 45. United States Vascular Protective Agents Revenue Growth 2019-2024 ($ millions)
Figure 46. Canada Vascular Protective Agents Revenue Growth 2019-2024 ($ millions)
Figure 47. Mexico Vascular Protective Agents Revenue Growth 2019-2024 ($ millions)
Figure 48. Brazil Vascular Protective Agents Revenue Growth 2019-2024 ($ millions)
Figure 49. APAC Vascular Protective Agents Sales Market Share by Region in 2023
Figure 50. APAC Vascular Protective Agents Revenue Market Share by Region (2019-2024)
Figure 51. APAC Vascular Protective Agents Sales Market Share byType (2019-2024)
Figure 52. APAC Vascular Protective Agents Sales Market Share by Application (2019-2024)
Figure 53. China Vascular Protective Agents Revenue Growth 2019-2024 ($ millions)
Figure 54. Japan Vascular Protective Agents Revenue Growth 2019-2024 ($ millions)
Figure 55. South Korea Vascular Protective Agents Revenue Growth 2019-2024 ($ millions)
Figure 56. Southeast Asia Vascular Protective Agents Revenue Growth 2019-2024 ($ millions)
Figure 57. India Vascular Protective Agents Revenue Growth 2019-2024 ($ millions)
Figure 58. Australia Vascular Protective Agents Revenue Growth 2019-2024 ($ millions)
Figure 59. ChinaTaiwan Vascular Protective Agents Revenue Growth 2019-2024 ($ millions)
Figure 60. Europe Vascular Protective Agents Sales Market Share by Country in 2023
Figure 61. Europe Vascular Protective Agents Revenue Market Share by Country (2019-2024)
Figure 62. Europe Vascular Protective Agents Sales Market Share byType (2019-2024)
Figure 63. Europe Vascular Protective Agents Sales Market Share by Application (2019-2024)
Figure 64. Germany Vascular Protective Agents Revenue Growth 2019-2024 ($ millions)
Figure 65.France Vascular Protective Agents Revenue Growth 2019-2024 ($ millions)
Figure 66. UK Vascular Protective Agents Revenue Growth 2019-2024 ($ millions)
Figure 67. Italy Vascular Protective Agents Revenue Growth 2019-2024 ($ millions)
Figure 68. Russia Vascular Protective Agents Revenue Growth 2019-2024 ($ millions)
Figure 69. Middle East & Africa Vascular Protective Agents Sales Market Share by Country (2019-2024)
Figure 70. Middle East & Africa Vascular Protective Agents Sales Market Share byType (2019-2024)
Figure 71. Middle East & Africa Vascular Protective Agents Sales Market Share by Application (2019-2024)
Figure 72. Egypt Vascular Protective Agents Revenue Growth 2019-2024 ($ millions)
Figure 73. South Africa Vascular Protective Agents Revenue Growth 2019-2024 ($ millions)
Figure 74. Israel Vascular Protective Agents Revenue Growth 2019-2024 ($ millions)
Figure 75.Turkey Vascular Protective Agents Revenue Growth 2019-2024 ($ millions)
Figure 76. GCC Countries Vascular Protective Agents Revenue Growth 2019-2024 ($ millions)
Figure 77. Manufacturing Cost Structure Analysis of Vascular Protective Agents in 2023
Figure 78. Manufacturing Process Analysis of Vascular Protective Agents
Figure 79. Industry Chain Structure of Vascular Protective Agents
Figure 80. Channels of Distribution
Figure 81. Global Vascular Protective Agents Sales MarketForecast by Region (2025-2030)
Figure 82. Global Vascular Protective Agents Revenue Market ShareForecast by Region (2025-2030)
Figure 83. Global Vascular Protective Agents Sales Market ShareForecast byType (2025-2030)
Figure 84. Global Vascular Protective Agents Revenue Market ShareForecast byType (2025-2030)
Figure 85. Global Vascular Protective Agents Sales Market ShareForecast by Application (2025-2030)
Figure 86. Global Vascular Protective Agents Revenue Market ShareForecast by Application (2025-2030)
